Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV
IntroductionVaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is an effective way of protecting individuals from severe coronavirus disease 2019 (COVID-19). However, immune responses to vaccination vary considerably. This study dynamically assessed the neutra...
Main Authors: | Yi Wang, Jianhua Li, Wenhui Zhang, Shourong Liu, Liangbin Miao, Zhaoyi Li, Ai Fu, Jianfeng Bao, Lili Huang, Liping Zheng, Er Li, Yanjun Zhang, Jianhua Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1152695/full |
Similar Items
-
STUDY OF THE EQUINE VIRAL ARTERITIS SEROCONVERSION AT HORSE STABLES IN THE TERRITORY OF VOJVODINA
by: Sava Lazić, et al.
Published: (2014-02-01) -
A Rare Case of Hepatitis Delta Co-Infection with Hbsag Seroconversion
by: Tuna Demirdal, et al.
Published: (2015-09-01) -
Intradermal vaccination of adults with three low doses (2 µg) of recombinant hepatitis B vaccine. I. Seroconversion rate and adverse effects
by: José Luís da S Baldy, et al.
Published: (2003-12-01) -
Seroconversion and adverse reaction of live-attenuated (OKA strain) varicella vaccine
by: Yulchair Ramli, et al.
Published: (2016-09-01) -
Seroconversion of hepatitis B surface antigen among those with previously successful immune response in Southern China
by: Zhigang Zheng, et al.
Published: (2021-03-01)